Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPowerhouse Ener Regulatory News (PHE)

Share Price Information for Powerhouse Ener (PHE)

Share Price is delayed by 15 minutes
Get Live Data
0.21    0.00 (0.00%)
Bid:
0.20
Ask:
0.22
Spread: 0.02 (10.00%)
Market Cap: £10.76m
PHE Live PriceLast checked at - London Stock Exchange

Intraday Powerhouse Ener Share Chart

Final Results

21 Jun 2010 07:00

RNS Number : 9154N
Bidtimes PLC
21 June 2010
 

21 June 2010

 

Bidtimes Plc

("the Company")

 

Final results for the ten month period ended 31 December 2009

 

Chairman's statement

 

I am pleased to present the final results of the Company for the ten month period ended 31 December 2009. The Company decided to change its accounting year end from 28 February to 31 December, as announced on 16 February 2010, to bring it in line with the calendar year.

 

During the period the Company continued to pursue the investment strategy as set out in the annual report to 28 February 2009, albeit with a limited budget in order to build value for its shareholders.

 

During the ten month period the Company made a loss of £101,358 after taxation, compared with a loss of £153,696 in the twelve months ended 28 February 2009.

 

Very limited exploration work has been carried out on the exploration licence over the Kyber Pass project, the Company's joint venture interest in South Australia.

 

Additionally, during the period under review the Company has continued to identify and assess other investment opportunities in the energy sector, particularly the alternative energy sector, in line with its investment strategy. The Company is also assessing an opportunity in the clean energy sector.

 

Despite the general lack of strategic direction from the Copenhagen Climate Conference in late 2009, the Directors believe that considerable opportunities exist within this industry with the potential to create shareholder value and these opportunities will be actively pursued.

 

 

 

A.T. Brennan

Executive Chairman

 

ENQUIRIES:

 

Bidtimes plc

 

Julian Moore, Non-Executive Director

 

T: +44 (0) 778 782 5269

Merchant John East Securities Limited (Nominated Adviser and Broker)

Simon Clements

David Worlidge

T: +44 (0) 20 7628 2200

Income Statement for the ten month period ended 31 December 2009

 

Note

 

Period ended

31 December

2009

 Year

ended

28 February

2009

£

£

Revenue

2

-

-

Administrative expenses

Amounts written off investments

-

(4,136)

Other administrative expenses

(101,486)

(153,137)

 

(101,486)

(157,273)

Operating loss

(101,486)

(157,273)

Loss on ordinary activities before taxation and finance costs

(101,486)

(157,273)

Finance income

332

3,814

Finance costs

(204)

(237)

Net finance income

128

3,577

Loss on ordinary activities before taxation

2

(101,358)

(153,696)

Taxation

3

-

-

Loss on ordinary activities after taxation

(101,358)

(153,696)

Attributable to:

Equity shareholders of the Company

(101,358)

(153,696)

Loss transferred to reserves

(101,358)

(153,696)

Basic loss per share (pence)

4

(0.10)p

(0.22)p

 

All activities relate to continuing operations.

Balance Sheet for the ten month period ended 31 December 2009

 

Note

 

As at

31 December

2009

As at

28

February

2009

£

£

Current assets

1,519

2,956

Trade and other receivables

5

219,318

319,897

Cash and cash equivalents

220,837

322,853

Total assets

220,837

322,853

Current liabilities

Trade and other payables

(40,695)

(41,353)

Total liabilities

(40,695)

(41,353)

Net assets

180,142

281,500

Shareholder funds

Issued capital

1,268,676

1,268,676

Share premium account

714,948

714,948

Retained earnings

(1,803,482)

(1,702,124)

 

Total equity

 

180,142

 

281,500

 

 

Cash flow statement for the ten month period ended 31 December 2009

 

 

Period ended

31 December

2009

 Year

ended

28 February

2009

£

£

Cash outflow from operating activities

(100,707)

(86,803)

Cash inflow from investing activities

Finance income received

332

3,814

Net cash inflow from investing activities

332

3,814

Cash (outflow)/inflow from financing activities

Finance cost paid

(204)

(237)

Proceeds from the issue of share capital

-

400,000

Net cash (outflow)/inflow from financing activities

(204)

399,763

Net (decrease)/increase in cash and cash equivalents

(100,579)

316,774

Cash and cash equivalents at beginning of period

319,897

3,123

Cash and cash equivalents at end of period

219,318

319,897

 

 

Statement of recognised income and expense for the ten month period ended 31 December 2009

 

Period ended

31 December

2009

 Year

ended

28 February

2009

£

£

Loss for the financial period

(101,358)

(153,696)

Total losses recognised since the last financial statements

 

(101,358)

 

(153,696)

Attributable to:

Equity Shareholders of the company

(101,358)

(153,696)

 

 

Notes to the financial statements for the ten month period ended 31 December 2009

1. Basis of preparation

The financial statements have continued to be prepared in accordance with IFRS (International Financial Reporting Standards) as adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

Bidtimes plc's financial statements were previously prepared in accordance with United Kingdom accounting standards (United Kingdom Generally Accepted Accounting Practice) until 28 February 2007. The date of transition to IFRS was 1 March 2007.

 

The preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts in the financial statements. The areas involving a higher degree of judgements or complexity, or areas where assumptions or estimates are significant to the financial statements are disclosed with the notes.

 

 

Going concern

Following the Company raising £440,000 by way of a placing in the prior financial year, a large portion of these funds remain on deposit within the Company, and are available to provide support for the financial operations of the Company. Therefore, after making enquiries, the board have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, the Directors believe that it is appropriate to prepare the financial statements on the going concern basis.

 

Revenue

 

Revenue is the total amount receivable by the company for services provided, including VAT.

 

Investments

 

Investments which are traded on an open market are included in the balance sheet at their open market values, other investments are included at cost. Impairment losses on investments are recognised in the profit and loss account, unless they arise on a previously revalued fixed asset. Impairment losses on revalued fixed assets are recognised in the statement of total recognised gains and losses until the carrying value of the asset falls below historical cost. Impairments below historical cost are recognised in the income statement.

 

Financial instruments

 

In accordance with IFRS 7 financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the income statement. Finance costs are calculated on a straight line basis.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Cash and cash equivalents

 

Cash and cash equivalent include cash at bank and in hand as well as short term highly liquid investments such as bank deposits.

Equity

 

Share capital is determined using the nominal value of shares that have been issued. Premiums received on the initial issuing of share capital have been credited to the share premium account and any costs incurred or associated with the issuing of shares have been deducted from share premium, net of any related income tax benefits.

Retained earnings include all current and prior period results as disclosed within the income statement.

2. Turnover and loss on ordinary activities before taxation

The turnover and loss on ordinary activities is stated after charging:

Period ended

31 December

2009

Year ended

28 February

2009

£

£

Auditors' remuneration

- audit services - statutory audit

5,875

5,750

Other interest payable

204

237

Provision for diminution in value write downs of investments

-

4,136

Bad debts

-

811

 

3. Taxation on loss on ordinary activities

No taxation charge arises on the loss for the period (Year ended 28 February 2009: £Nil).

 

The tax assessed for the year is different to the standard rate of corporation tax in the UK of 28 per cent. (Year ended 28 February 2009: 28.2 per cent.). The differences are explained as follows:

 

Period ended 31 December 2009

Year ended

28 February 2009

£

£

Loss on ordinary activities before tax

(101,358)

(153,696)

Loss on ordinary activities before tax multiplied by the standard rate of corporation tax in the UK of 28%

(Year ended 28 February 2009: 28.2%)

(28,380)

(43,342)

Effect of:

Disallowable expenses

-

11,326

Losses carried forward

28,380

32,016

Current tax charge for year

-

-

 

Unrelieved trading tax losses of £827,301 (Year ended 28 February 2009: £725,943) are available to offset against future taxable trading profits.

 

4. Loss per share

The calculation of the basic loss per share is based on the loss on ordinary activities after tax and on the weighted average number of ordinary shares in issue during the period. The impact of the share options is anti dilutive.

 

31 December 2009

28 February 2009

 

 

Loss

£

Weighted average number of shares

Loss per share (pence)

 

 

Loss

£

Weighted average number of shares

Loss per share (pence)

Basic loss per share

 

(101,358)

 

97,373,523

 

(0.10)

 

(153,696)

 

70,633,797

 

(0.22)

 

5. Cash and cash equivalents

Cash and cash equivalents comprise of the following components:

 

Period ended

31 December

2009

Year ended

28 February

2008

£

£

Current accounts

17,108

48,019

Deposit accounts

202,210

271,878

219,318

319,897

 

6. Reconciliation of net cash flow to movement in net funds

Period ended

31 December

2009

Year ended

28 February

2009

£

£

(Decrease)/Increase in cash

(100,579)

316,774

Net proceeds from disposal of freehold property investment

-

-

(100,579)

316,774

Net funds at the beginning of the year

319,897

3,123

Net funds at the end of the year

219,318

319,897

 

7. Reconciliation of cash outflow from operating activities

Period ended

31 December

2009

Year ended

28 February

2009

£

£

Operating loss

(101,486)

(157,273)

Decrease in debtors

1,437

56,752

(Decrease)/Increase in creditors

(658)

9,582

Amounts written off investments

-

4,136

Net cash outflow from operating activities

(100,707)

(86,803)

 

8. Analysis of changes in cash and cash equivalents and net funds

At

1 March

2009

Cash flow

 

Non cash

movement

At

31 December

2009

£

£

£

£

Cash at bank and in hand

319,897

(100,579)

-

219,318

Cash and cash equivalents

319,897

(100,579)

-

219,318

319,897

(100,579)

-

219,318

 

9. Post balance sheet events

Since the balance sheet date the Company has continued to identify and assess other investment opportunities in the energy sector, particularly the alternative energy sector in line with its investment strategy and is also currently assessing an opportunity in the clean energy sector.

 

10. Dividend

The Directors do not recommend the payment of a dividend.

 

11. Availability of report and accounts

Copies of the report and accounts will be posted to shareholders shortly, will be available from the Company's registered office, Meriden House, 6 Great Cornbow, Halesowen, West Midlands B63 3AB and from the Company's website www.bidtimes.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR QBLFLBQFEBBQ
Date   Source Headline
2nd Jun 20265:00 pmRNSOversubscribed Retail Offer and TVR
1st Jun 20267:05 amRNSRetail Offer through the BookBuild platform
1st Jun 20267:00 amRNSResults of Placing and TVR
29th May 20261:45 pmRNSProposed Placing and Retail Offer
18th May 20267:00 amRNS-REnergy From Waste Innovation Award
14th May 202612:57 pmRNSResult of General Meeting and TVR
28th Apr 20267:00 amRNSOperational Update
27th Apr 20267:00 amRNSOversubscribed Retail Offer
23rd Apr 20267:05 amRNSRetail Offer through the BookBuild Platform
23rd Apr 20267:00 amRNSConditional Placing to Raise £400,000
13th Apr 20267:00 amRNS-RGranting of non-exclusive licence to HUI
17th Mar 20269:20 amRNS-RPublication of Research Report
2nd Mar 20267:00 amRNSMENA, GCC and Asia Marketing Agreement
28th Jan 20267:00 amRNSSubmission of Planning Application
26th Jan 20267:00 amRNSSigning of Agreement to Lease Site in Ballymena
5th Dec 20257:00 amRNSChange of Advisers
1st Dec 20257:00 amRNSAustralian Project update
24th Nov 20257:00 amRNSEngsolve Trading update
20th Nov 20257:00 amRNSFurther Patent Grants
18th Sep 20257:00 amRNSFeedstock Testing Unit update
16th Sep 20257:00 amRNSHalf Year Report for 6 months ended 30 June 2025
1st Sep 20257:00 amRNS-RPublication of Research Report
31st Jul 202512:36 pmRNSDirector’s Dealing
10th Jul 20252:12 pmRNSResult of AGM
10th Jul 20257:00 amRNSAGM Update
3rd Jul 20257:00 amRNS-RLetter of Intent – Hydrogen offtake, Ballymena, NI
30th Jun 20257:00 amRNSCompletion of FEED for NH2
10th Jun 20257:00 amRNSAudited Results for Year Ended 31 December 2024
29th May 20252:36 pmRNS-RNew Website
22nd May 20257:00 amRNS-RFurther Patent Grants
20th May 20258:52 amRNSEngsolve Trading update
25th Apr 20252:31 pmRNSDirector’s Dealing
20th Mar 20257:00 amRNSResult of Retail Offering and TVR
14th Mar 20255:15 pmRNSRetail Offer
14th Mar 20255:15 pmRNS£1.25m Placing, Options Grant, Retail Offer & TVR
4th Mar 20257:00 amRNSCapital Markets Day Presentation
10th Feb 20257:00 amRNS-RNotice of Capital Markets Day
20th Jan 20257:00 amRNS-RProposed collaboration agreement with Avioxx
16th Dec 20247:00 amRNSTechnical Centre Update – Mechanical Completion
18th Nov 20247:00 amRNSAward of FEED to Engsolve
11th Nov 20247:00 amRNSJapanese Patent Grant Confirmed
25th Oct 20244:13 pmRNSAward of share options
15th Oct 20247:00 amRNSEuropean Patent Grant Confirmed
30th Sep 20247:00 amRNSDirector’s Dealing
19th Sep 20247:00 amRNSHalf Year Report for six months ended 30 June 2024
7th Aug 20247:00 amRNSAppointment of Broker
28th Jun 20247:00 amRNSResult of AGM
19th Jun 20247:00 amRNSDelivery of Kiln to Technical Centre
10th Jun 20247:00 amRNSDirectorate Update
7th Jun 20241:21 pmRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.